FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 278 of 278

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
TNGX Nasdaq Tango Therapeutics, Inc. 2830
TNYA Nasdaq Tenaya Therapeutics, Inc. 2830
TRVI Nasdaq Trevi Therapeutics, Inc. 2830
TTRX Nasdaq Turn Therapeutics Inc. 2830
TYRA Nasdaq Tyra Biosciences, Inc. 2830
UCBJY Over the counter UCB SA 2830
UNCY Nasdaq Unicycive Therapeutics, Inc. 2830
URGN Nasdaq UroGen Pharma Ltd. 2830
UTHR Nasdaq United Therapeutics Corporation 2830
VERU Nasdaq Veru Inc. 2830
VNDA Nasdaq Vanda Pharmaceuticals Inc. 2830
VOR Nasdaq Vor Biopharma Inc. 2830
VRTX Nasdaq Vertex Pharmaceuticals Incorporated 2830
VTGN Nasdaq Vistagen Therapeutics, Inc. 2830
VTVT Nasdaq vTv Therapeutics Inc. 2830
VYNE Nasdaq VYNE Therapeutics Inc. 2830
WALD Nasdaq Waldencast plc 2830
WVE Nasdaq Wave Life Sciences Ltd. 2830
XBIT Nasdaq XBiotech Inc. 2830
XCUR Nasdaq Exicure, Inc. 2830
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2830
XNCR Nasdaq Xencor, Inc. 2830
XOMA Nasdaq XOMA Royalty Corporation 2830
XTLB Nasdaq XTL Biopharmaceuticals Ltd. 2830
ZEOX Over the counter Zeo ScientifiX, Inc. 2830
ZURA Nasdaq Zura Bio Limited 2830
ZVRA Nasdaq Zevra Therapeutics, Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 278 of 278